Sign In

February 4, 2018
A new study finds that lifelong intake of fish or sunflower oil may damage the liver in a way that increases the risk of non-alcoholic fatty liver disease.
February 1, 2018
Learn about the relationship between baby boomers and hepatitis C, and why people born between 1945 and 1965 should be tested for the disease.
June 30, 2017

Alexandria, VA – The American Association for the Study of Liver Diseases Foundation, the largest private supporter of liver disease research and training in the United States, today announced its investment of $3.34 million in research and career development funding granted to 25 researchers and clinicians to conduct innovative liver disease research and seek advanced hepatology training.

July 19, 2016

HCVguidelines.org, a website developed by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) to provide up-to-date guidance on the treatment of hepatitis C (HCV) has updated several sections of the website based on newly available therapies and data.

November 10, 2014

It is estimated that 2.4 percent of New York City (NYC) residents have HCV infection, but half do not know their status. To address this gap, the NYC Department of Health and Mental Hygiene launched the Check Hep C Program, which, in its first year, helped increase the rate of complete hepatitis C (HCV) diagnostic testing among at risk populations and has successfully linked more people to HCV... More

November 10, 2014

Liver transplantation is a therapeutic option for selected patients with liver cancer with high 5-year survival rates of 75 – 80 percent. HIV-infected patients often do not have access to liver transplantation, and experience with HIV-infected patients with liver cancer undergoing liver transplantation is limited.

November 10, 2014

Researchers from MD Anderson reported at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) their attempt to estimate the cost of treating all patients in the United States with hepatitis C virus (HCV) and compare it to the potential cost savings.

November 10, 2014

The newest and most effective drugs for the treatment of hepatitis C have a cure rate of up to 98 percent, but the cost of these therapies has been controversial. Accurately assessing the cost of treating all patients with HCV in the US has yet to be determined.

November 9, 2014

Attendees of the annual meeting of the American Association for the Study of Liver Diseases (AASLD) listened to the results of a study on the adherence to its practice guidelines on testing for hepatitis B virus (HBV). Drs. Marina Serper, Kimberly Forde, and David E. Kaplan, of the University of Pennsylvania and Philadelphia VA Medical Center, examined the VA’s Corporate Data Warehouse and... More

Pages